For Startups – Advisory & Acceleration

Why It Matters

Deeptech and life science startups often develop groundbreaking technology, but struggle to explain it, fund it, and commercialize it. BCG shows that only 25% of deeptech startups reach scale, mostly due to unclear market paths and lack of investor readiness. Strong storytelling, structured GTM, and the right connections make the difference between staying niche and scaling globally.

The Challenge for Startups

Founders face a unique set of barriers in regulated industries:

• Complex storytelling: hard to communicate advanced science simply.
  
• Limited GTM experience: most teams know research, not SaaS commercialization.
  
• Fundraising pressure: time-consuming investor processes drain focus.
  
• Network gaps: few direct links to pharma, OEMs, or relevant investors.
  
  

How I Help

I support founders with tailored advisory, hands-on mentoring, and ecosystem access:

• Investor Readiness: refine deck, financials, and investor Q&A.
  
• GTM Roadmap: define ICP, early markets, and pricing models.
  
• Pilot & Customer Engagement: design pilot proposals for pharma and OEM partners.
  
• Ecosystem Access: connect to investors, corporates, and clusters.
  
  

My Experience

As co-founder of the Science Entrepreneur Club, we support 420+ startups and 420+ investors. At Clustermarket, I gained operator experience building traction with pharma, biotech, and academic labs, which gives me a practical view of early adoption challenges.